Skip to main content

Post-IPO Equity Companies in Palo Alto

Explore 9 post-ipo equity startups based in Palo Alto, United States. Access verified founder contact information and fundraising data.

Total Companies
9
Total Funding
$1.4B
Avg Funding
$159.4M
Industries
6

Export 9 Post-IPO Equity Companies in Palo Alto

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
$150.0M
raised

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

Aug 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$1.0B
raised

BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biopharma
$25.0M
raised

Peak Bio is a biopharmaceutical company that focuses on the drug development to treat Oncology and Inflammatory diseases.

Apr 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Advanced Materials
$15.1M
raised

Palomino Laboratories develops compound semiconductor and MicroLED-based optical interconnect technologies for AI and data communication.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$16.5M
raised

Vincerx Pharma is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology.

Apr 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 9 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cloud Infrastructure
$3.0M
raised

Cloudastructure provides cloud based infrastructure for building automation - providing VSaaS, ACaaS, and Custom IoT integration solutions

Apr 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$125.0M
raised

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$20.3M
raised

Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Delivery
$80.0M
raised

Enjoy is a technology platform that provides personalized retail shopping.

Oct 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Connect with Post-IPO Equity Startups in Palo Alto?

Get verified founder emails, funding details, and company data for 9 post-ipo equity companies in Palo Alto.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked